The early preclinical and clinical development of cipargamin (KAE609), a novel antimalarial compound

Bouwman, Suzan A. M.; Zoleko-Manego, Rella; Renner, Katalin Csermak; Schmitt, Esther K.; Mombo-Ngoma, Ghyslain; Grobusch, Martin P.

dc.contributor.author	Zoleko-Manego, Rella
dc.contributor.author	Mombo-Ngoma, Ghyslain
dc.contributor.author	Grobusch, Martin
dc.date.accessioned	2021-06-22T06:54:07Z
dc.date.available	2021-06-22T06:54:07Z
dc.date.issued	2020
dc.identifier.issn	1873-0442
dc.identifier.uri	http://hdl.handle.net/10900/116383
dc.language.iso	en	de_DE
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.tmaid.2020.101765	de_DE
dc.subject.ddc	300	de_DE
dc.subject.ddc	610	de_DE
dc.title	The early preclinical and clinical development of cipargamin (KAE609), a novel antimalarial compound	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210304112512_01804
utue.personen.roh	Bouwman, Suzan A. M.
utue.personen.roh	Zoleko-Manego, Rella
utue.personen.roh	Renner, Katalin Csermak
utue.personen.roh	Schmitt, Esther K.
utue.personen.roh	Mombo-Ngoma, Ghyslain
utue.personen.roh	Grobusch, Martin P.
dcterms.isPartOf.ZSTitelID	Travel Medicine and Infectious Disease	de_DE
dcterms.isPartOf.ZS-Issue	Article 101765	de_DE
dcterms.isPartOf.ZS-Volume	36	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE